You have 9 free searches left this month | for more free features.

Condition

Advanced Cancer (1)

Endometrial Cancer (1)

Metastatic Cancer (1)

Neoplasms (1)

Non Small Cell Lung Cancer (1)

Non Small Cell Lung Cancer Metastatic (1)

Non Small Cell Lung Cancer Stage IIIB (1)

Solid Tumor (1)

Overall Status

Active, not recruiting (1)

Recruiting (1)

Phase

phase 1 (1)

phase 3 (1)

Sponsor

ARCAGY/ GINECO GROUP (1)

Tesaro, Inc. (1)

Collaborator

GlaxoSmithKline (1)

Intervention

carboplatin-paclitaxel (2)

bevacizumab (1)

carboplatin-nab-paclitaxel (1)

carboplatin-pemetrexed (1)

dostarlimab (1)

niraparib (1)

tsr-022 (1)

tsr-042 (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (2)

carboplatin-paclitaxel

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Tumors, Metastatic Cancer, Advanced Cancer Trial in United States (Niraparib, TSR-042, Carboplatin-Paclitaxel)

Active, not recruiting

Has Results

Neoplasms
+6 more

Niraparib
+6 more

Scottsdale, Arizona
+7 more

Oct 31, 2022

Endometrial Cancer Trial in France (Carboplatin-Paclitaxel, Dostarlimab)

Recruiting

Endometrial Cancer

Carboplatin-Paclitaxel
Dostarlimab

Angers, France
+40 more

Aug 9, 2022